All Immunology articles – Page 14
-
NewsValneva provides update on Chikungunya vaccine IXCHIQ®
Valneva SE has announced that the company has decided to voluntarily withdraw the biologics license application (BLA) and Investigational New Drug (IND) application for its chikungunya vaccine, IXCHIQ® , in the United States, following suspension of the license by the FDA.
-
NewsShingles vaccine linked to slower biological aging in older adults
Shingles vaccination not only protects against the disease but may also contribute to slower biological aging in older adults, according to a new study.
-
NewsProject to combat childhood diarrhea receives over 5 million euros
A new project will use probiotics, improved education in hygiene and advanced mathematical models to prevent children from dying of diarrhea in low and middle-income countries.
-
NewsInfant gut bacteria may be the key to preventing asthma and allergies
A study shows that children are less likely to develop allergies and asthma if, as infants, they are colonized with certain bifidobacteria that produce a substance in the gut - a so-called metabolite - that dampens immune responses to allergens.
-
NewsShould younger and older people receive different treatments for the same infection?
Scientists find the mechanisms young mice use to fight sepsis become disadvantageous in older age, suggesting age-specific treatments may be necessary in ongoing antibiotic resistance crisis.
-
NewsGut bacteria molecule boosts lung cancer treatment response
Researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy treatment in mice and can now be made into a drug for testing in humans.
-
NewsTB and HIV treatments are not enough for a full recovery
Existing treatments control TB and HIV, but the immune system does not revert to normal, helping explain why people living with HIV remain susceptible to infections and underscoring the need for immunotherapies.
-
NewsWhen a virus releases the immune brake: New evidence on the onset of multiple sclerosis
A study investigating the links between Epstein-Barr virus and multiple sclerosis shows that EBV can interfere with the control of B cells. One viral protein mimics a crucial “approval” signal that B cells usually require from other immune cells. Self-reactive B cells can then survive even when they should be shut down.
-
NewsResearch reveals hidden diversity of E. coli driving diabetic foot infections
New research has shed light on the diversity and characteristics of E. coli strains that drive diabetic foot infections, providing the first comprehensive genomic characterisation of E. coli strains isolated directly from diabetic foot ulcers across multiple continents.
-
NewsNew mechanism links Epstein-Barr virus to MS
Scientists investigating the links between the Epstein-Barr virus and multiple sclerosis show that when the immune system fights EBV, certain T cells – which normally attack the virus – can also react to a protein in the brain called Anoctamin-2 (ANO2), a phenomenon called molecular mimicry.
-
NewsNew test could help pinpoint IBD diagnosis, study finds
A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests. The luminescent reporter lights up when it detects a molecule linked to gut inflammation.
-
NewsA protein found in the GI tract can neutralize many bacteria
The mucosal surfaces that line the body are embedded with defensive molecules that help keep microbes from causing inflammation and infections. One of these molecules, intelectin-2, has broad-spectrum antimicrobial activity against bacteria found in the GI tract.
-
NewsCat disease challenges what scientists thought about coronaviruses
Researchers have uncovered new details about how a once-deadly coronavirus disease in cats spreads through the immune system. For years, the prevailing belief was that the virus behind feline infectious peritonitis infected just one type of immune cell.
-
NewsA simple blood test can predict Crohn’s disease years before symptoms appear
Researchers have shown a blood test can predict Crohn’s disease years before symptoms appear, opening the doors to early diagnosis and potentially prevention. The test measures a person’s immune response to flagellin, a protein found on gut bacteria.
-
NewsTB harnesses part of immune defense system to cause infection
Scientists have made a discovery that helps explain why humans and animals are so susceptible to contracting tuberculosis – and it involves the bacteria harnessing part of the immune system meant to protect against infection. They team discovered that MTB survives within the cells of its host by targeting Dectin-1.
-
NewsVictoria’s Secret grant backs cutting-edge ovarian cancer research
Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has won $700,000 in support from the Victoria’s Secret Global Fund for Women’s Cancers in partnership with Pelotonia and AACR, the American Association for Cancer Research.
-
NewsNewly discovered gut microbial molecules in infancy may influence the risk of type 1 diabetes
An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important role in shaping the developing immune system during early childhood.
-
NewsWhooping cough vaccination for pregnant women strengthens babies’ immune system
Vaccinating women during pregnancy leads to the transfer of antibodies to their newborns. These antibodies were detected not only in blood, but also in the nasal mucosa, the site where whooping cough bacteria enter the body.
-
NewsCommon brain parasite can infect your immune cells. Here’s why that’s probably OK
Researchers have determined how our immune systems fight back against the parasite Toxoplasma gondii when it makes it inside the CD8+ T cells meant to destroy it.
-
NewsCholera vaccine completes phase 1 trial
A clinical trial shows promising results for PanChol, a single-dose oral vaccine aimed at the up to 4 million annual cholera cases worldwide.